期刊文献+

塞克硝唑治疗滴虫阴道炎84例疗效观察

Clinical effect of secnidazole tablet in the treatment of 84 cases suffered trichomonal vaginitis
原文传递
导出
摘要 目的 评价口服塞克硝唑片治疗滴虫阴道炎的有效性和安全性。方法 采用随机双盲、平行对照设计、入选滴虫阴道炎患者84例.塞克硝唑片组与替硝唑片组各42例.对其临床疗效和滴虫清除率进行比较,并观察用药后不良事件和实验室检查异常的发生情况。结果用药后塞克硝唑片组痊愈率和有效率分别为35.0%和92.5%;替硝唑片组痊愈率和有效率分别为19.5%和92.7%.两组之间比较差异无统计学意义(P〉0.05)塞克硝唑片组滴虫清除率为95.2%;替硝唑片组滴虫清除率为97.6%.两组之间比较差异无统计学意义(P〉0.05)。84例病例中无不良事件与严重不良事件发生;塞克硝唑片组实验室检查异常发生率为0.00%、替硝唑片组实验室检查异常发生率为7.14%.两组之间比较差异无统计学意义(P〉0.05)。结论 口服塞克硝唑片治疗滴虫阴道炎安全、有效。 Objective To evaluate the efficacy and safety of secnidazole tablet in the treatment of trichomonal vaginitis. Methods A randomized,double-blinding,parallel-controlled clinical trial including 84 cases suffered trichomonal vaginitis was conducted. 42 cases in trial group were given secnidazole tablets and 42 cases in control group were given tinidazole tablets. The clinical efficacy and the eradicated rates of trichomonad were compared between trial group and control group. The adverse events and abnormal results of laboratory test were observed. Results After treatment, the cure rates were 35.0 % in trial group and 19.5 % in control group, the efficacy rates were 92.5 % in trial group and 92.7 % in control group. There were no significant differences between two groups( P 〉 0.05 ). The eradicated rates of trichomonad were 95.2 % in trial group and 97.6 % in control group. There were no significant differences between two groups in eradicated rates of trichomonad (P 〉 0.05 ). There were no adverse events and severe adverse.events happened in all these 84 cases. The rates of abnormal results of laboratory test were 0.00 % in trial group and 7.14 % in control group. There were no significant differences between two groups in safety(P 〉 0.05). Conclusion Secnidazole tablet is effect and safe in the treatment of trichomonal vaginitis.
出处 《中国基层医药》 CAS 2007年第6期881-883,共3页 Chinese Journal of Primary Medicine and Pharmacy
关键词 滴虫阴道炎 塞克硝唑 替硝唑 Trichomonal vaginitis Secnidazole Tinidazole
  • 相关文献

参考文献6

  • 1张彤,杨文方,倪宗瓒,李芬,孙长田,金辉,于学文,王凤琴,韩蓁,任永惠,王懿,李学成,胡长江,高治民.贫困地区育龄妇女滴虫性阴道炎相关因素分析[J].四川大学学报(医学版),2005,36(1):101-104. 被引量:21
  • 2Gillis JC,Wiseman LR. Secnidazole. A review of its antimicrobial activity, pharmacokinetic properties and therapeutic use in the management of protozoal infections and bacterial vaginosis. Drugs, 1996,51 (4) :621-638.
  • 3张立红,吴松.塞克硝唑的药理及临床应用[J].中国新药杂志,2002,11(10):765-766. 被引量:28
  • 4徐颖颖,陈小青,阚连娣.塞克硝唑体内外抗厌氧菌效果的研究[J].中国现代应用药学,2003,20(2):91-94. 被引量:17
  • 5Mammen-Tobin A, Wilson JD. Management of metronidazole resistant trichomonas vaginalis:a new approach. Int J STD AIDS,2005, 16:488-490.
  • 6Bagnoli VR. An overview of the clinical experience with secnidazole in bacterial vaginosis and thichomoniasis. Drug Invest, 1994,8(Suppl 1 ) :S53-S60.

二级参考文献18

  • 1钱序,蔡文玮.中国妇女生殖道感染研究现状(上)[J].中国妇幼保健,1994,9(2):58-60. 被引量:29
  • 2钱序,蔡文玮.中国妇女生殖道感染研究现状(下)[J].中国妇幼保健,1994,9(3):52-54. 被引量:23
  • 3唐汉祥.替硝唑的临床药理研究[J].中国新药杂志,1997,6(3):180-182. 被引量:13
  • 4严杰.口腔厌氧菌的药物敏感试验[A].陈莉丽 章锦才 严杰主编.口腔厌氧菌和牙周病[C].北京:人民卫生出版社,1998.196.
  • 5刘民 梁万年.男性参与对生殖健康的影响[J].生殖健康,1998,2(1):10-12.
  • 6Xiang-sheng Chen, Xiang-dong Gong. Epidemiologic trends of sexually transmitted diseases in China. Sexually Transmitted Disease,2000;3:141.
  • 7World Health Organization. Global program on AIDS. Geneva, Switzerland, 1995b.
  • 8Brabin L, Kemp J, Dollimore N, et al. Reproductive tract infections and abortion among adolescent girls in rural Nigeria. The Lancet,1995;345(4):300.
  • 9Bang RA, Baitule M, Sarmukaddam S, et al. High prevalence of gynecologic disease in rural India women. The Lancet,1989;14(1):85.
  • 10Bhatia JC, Cleand J. Self-reported symptoms of gynecological morbidity and their treatment in south India. Studying in Family Planning,1995;26(4):203.

共引文献49

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部